Randall Brand

Works at

Sources: reporter.nih.gov

Grants and prizes

  • National Cancer Institute

    U01, Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions, U01CA274514, 2023–2028, 3 Jul 2026

  • National Cancer Institute

    U01, Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma, U01CA200466, 2016–2028, 1 Apr 2026

  • National Cancer Institute

    R01, Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer, R01CA254036, 2021–2027, 28 Feb 2025

Sources: reporter.nih.gov